Abstract
Umbralisib (UKONIQ (TM)) is an oral, first-in-class dual phosphatidylinositol 3-kinase delta (PI3K delta) and casein kinase 1 epsilon (CK1 epsilon) in......
小提示:本篇文献需要登录阅读全文,点击跳转登录